Dave Duarte
Host
Replay available
Surgery Partners, Inc. (NASDAQ: SGRY) Q3 2025 earnings conference call, held 2025-11-10. Replay captured from the company's public earnings webcast.

Host
Chief Executive Officer
Analyst, Jefferies
Analyst, Bank of America
Analyst, J.P. Morgan
Analyst, KeyBank Capital Markets
Analyst, RBC Capital Markets
Analyst, Barclays
Analyst, Cantor Fitzgerald
Analyst, LeeRink Partners
Analyst, The Benchmark Company
Analyst, TD Cowan
Greetings and welcome to the Surgery Partners third quarter 2025 earnings call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note this conference is being recorded. I will now turn the conference over to your host, Dave Duarte. Please go ahead. Good morning, and thank you for joining Surgery Partners' third quarter 2025 earnings call. I am joined today by Eric Evans, our CEO. During this call, we will make forward-looking statements. There are risk factors that could cause future results to be materially different from these statements, as described in this morning's press release and the reports we file with the SEC, each of which are available on our corporate website. The company does not undertake any duty to update these forward-looking statements. In addition, we reference certain financial measures that are non-GAAP, which we believe can be useful in evaluating our performance. We reconcile these measures to the most applicable GAAP measure in this morning's press release. With that, I will turn the call over to Eric. Thank you, Dave. Good morning, and thank you all for joining us today. My opening comments will briefly highlight our third quarter results, which reflect continued execution and consistency with our long-term growth algorithms. Then, I will discuss in more detail our recent progress across our three growth pillars, organic growth, margin improvement, and deploying capital for M&A. I will also provide some additional color on our ongoing strategic portfolio optimization process before concluding with some commentary on our outlook for the remaind...